| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $430.5M | +22.7% |
| Cost of Revenue | $123.7M | +10.9% |
| Gross Profit | $306.9M | +28.2% |
| R&D Expense | $113.6M | +21.1% |
| SG&A Expense | $87.2M | +7.7% |
| Operating Income | -$32.2M | +53.5% |
| Pre-tax Income | -$29.9M | +57.2% |
| Income Tax | $2.1M | +527.3% |
| Net Income | -$32.0M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $208.4M | +59.8% |
| Accounts Receivable | $95.1M | +2.3% |
| Current Assets | $342.7M | +34.5% |
| Total Assets | $733.0M | +16.6% |
| Current Liabilities | $300.6M | +15.9% |
| Total Liabilities | $329.8M | +14.6% |
| Stockholders' Equity | $403.2M | +18.2% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $67.2M | +144.6% |
| Capital Expenditures | $2.5M | +11.1% |
| Investing Cash Flow | -$19.8M | -38.3% |
| Financing Cash Flow | $30.3M | -52.7% |
| Free Cash Flow | $64.8M | +156.3% |
| +53.9% |
| EPS (Basic) | -$0.45 | +58.3% |
| EPS (Diluted) | -$0.45 | +58.3% |